معرفی
Deepa Camenga, MD, MHS, FAAP is an Associate Professor of Emergency Medicine at Yale School of Medicine with secondary appointments in Chronic Disease Epidemiology and General Pediatrics. She serves as the Associate Director of Pediatric Programs for the Yale Program in Addiction Medicine, where she leads clinical, educational, and policy efforts to improve healthcare for children impacted by substance use. As a board-certified physician in pediatrics and addiction medicine, Dr. Camenga specializes in adolescent addiction and is one of the few clinicians in Connecticut who prescribes medication treatment for adolescents with opioid use disorder.
Dr. Camenga's educational background includes:
- BA from Yale University (2000)
- MD from University of Rochester School of Medicine & Dentistry (2005)
- Residency at University of Rochester Golisano Children Hospital (2008)
- Chief Resident at Children's Strong Hospital, Rochester (2009)
- Postdoctoral Fellowship and MHS in Health Services Research through the Robert Wood Johnson Foundation Clinical Scholars Program at Yale (2012)
Dr. Camenga's research focuses on reducing the morbidity and mortality associated with adolescent substance use and substance use disorders. Her work specifically aims to improve identification and treatment of drug and tobacco use in healthcare settings, with a particular interest in developing technology-enhanced interventions to reduce substance use among adolescents and young adults. She employs both quantitative and qualitative methodologies to examine adolescent substance use patterns, cessation motivations, and the effectiveness of interventions in clinical and community settings. Her research has significant implications for public health policy and clinical practice guidelines related to youth substance use.
Dr. Camenga's recent publications demonstrate a strong focus on adolescent vaping behaviors, impaired driving among youth, and digital interventions for substance use prevention. Her work spans multiple methodologies including longitudinal studies, system dynamics modeling, and mixed-methods approaches. Key themes in her research include the impact of flavored products on youth nicotine dependence, the social and environmental factors influencing risky behaviors, and the development of evidence-based approaches to substance use prevention and treatment for adolescents.
Dr. Camenga is actively involved in national professional organizations and committees:
- Member of the American Academy of Pediatrics Committee on Substance Use and Prevention (since 2016)
- Member of the American Academy of Pediatrics Meeting Planning and Participation Committee (since 2018)
- Former Committee Member of the Academic Pediatric Association (2013-2015)
Dr. Camenga has developed several innovative clinical programs, including a school-based health center tele-consult program and an inpatient adolescent addiction medicine consult service. She treats adolescents and young adults at the APT Foundation and leads an addiction medicine tele-consult service for local school-based health centers. Her work extends to the Yale DrivSim Lab, where she collaborates on studies examining the neurocognitive aspects of risky driving and substance use among youth. Dr. Camenga also chairs the American Academy of Pediatrics Committee on Substance Use and Prevention, positioning her as a national expert in pediatric addiction medicine.
